[go: up one dir, main page]

CN104086550A - Synthetic method for tetramethyluric acid - Google Patents

Synthetic method for tetramethyluric acid Download PDF

Info

Publication number
CN104086550A
CN104086550A CN201410344230.XA CN201410344230A CN104086550A CN 104086550 A CN104086550 A CN 104086550A CN 201410344230 A CN201410344230 A CN 201410344230A CN 104086550 A CN104086550 A CN 104086550A
Authority
CN
China
Prior art keywords
pressure
autoclave
uric acid
acid
tetramethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410344230.XA
Other languages
Chinese (zh)
Other versions
CN104086550B (en
Inventor
陈福欣
龚频
周安宁
贺诗华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xian University of Science and Technology
Original Assignee
Xian University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xian University of Science and Technology filed Critical Xian University of Science and Technology
Priority to CN201410344230.XA priority Critical patent/CN104086550B/en
Publication of CN104086550A publication Critical patent/CN104086550A/en
Application granted granted Critical
Publication of CN104086550B publication Critical patent/CN104086550B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/14Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with two methyl radicals in positions 1 and 3 and two methyl radicals in positions 7, 8, or 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种四甲基尿酸的合成方法,该方法为:一、将尿酸和甲基化试剂置于高压反应釜内,保护气体置换三次后充保护气体至高压反应釜内压力为0.5MPa~10MPa,升温至84℃~220℃,搅拌条件下保温反应;二、采用冷凝水对保温反应后的高压反应釜降温,并打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入冰水中进行搅拌析晶,抽滤后得到粗品;三、对粗品进行重结晶,干燥后得到质量纯度不小于95%的四甲基尿酸。本发明以尿酸为原料,经嘌呤环上氮的完全甲基化反应在高压、高温条件下得到产物四甲基尿酸,具有高转化率、高产率、高选择性和反应时间短等优势,适用于规模化合成。The invention discloses a method for synthesizing tetramethyluric acid. The method is as follows: 1. Put uric acid and a methylating reagent in a high-pressure reactor, replace the protective gas for three times, and then fill the protective gas until the pressure in the high-pressure reactor is 0.5 MPa~10MPa, heat up to 84°C~220°C, heat preservation reaction under stirring conditions; 2. Use condensed water to cool down the high-pressure reaction kettle after heat preservation reaction, and open the outlet valve of the high-pressure reaction kettle to release the pressure, and wait for the pressure of the high-pressure reaction kettle to drop When it reaches 0MPa, open the kettle and discharge the material, pour the reacted material into ice water for stirring and crystallization, and obtain the crude product after suction filtration; 3. Recrystallize the crude product, and obtain tetramethyluric acid with a mass purity of not less than 95% after drying . The present invention uses uric acid as a raw material to obtain the product tetramethyluric acid under high pressure and high temperature conditions through the complete methylation reaction of nitrogen on the purine ring, which has the advantages of high conversion rate, high yield, high selectivity and short reaction time, and is suitable for synthesized on a large scale.

Description

一种四甲基尿酸的合成方法A kind of synthetic method of tetramethyluric acid

技术领域technical field

本发明属于药物合成、有机合成技术领域,具体涉及一种四甲基尿酸的合成方法。The invention belongs to the technical fields of drug synthesis and organic synthesis, and in particular relates to a synthesis method of tetramethyluric acid.

背景技术Background technique

四甲基尿酸(theacrine)是黄嘌呤类生物碱,与茶碱、咖啡因、可可碱等的结构类似,具有多种生理活性,如抗炎、镇痛等。近年来的研究则集中在其血脑屏障的通透性及中枢神经作用。之前的实验研究表明,该类生物碱在帕金森病模型小鼠中可能对多巴胺神经元具有保护作用,能够防止或延缓其退化,非常有望开发成为治疗帕金森病的新型药物。Tetramethyluric acid (theacrine) is a xanthine alkaloid, which is similar in structure to theophylline, caffeine, and theobromine, and has various physiological activities, such as anti-inflammatory and analgesic. In recent years, studies have focused on the permeability of the blood-brain barrier and the role of the central nervous system. Previous experimental studies have shown that this type of alkaloid may have a protective effect on dopamine neurons in Parkinson's disease model mice, and can prevent or delay its degeneration, and is very promising to be developed as a new drug for the treatment of Parkinson's disease.

Theacrine来源于中国南方的苦茶中,其中(Theobromagrandiflorum)和Camellia kucha(Camellia assamica var.kucha)中的含量相对较高,现有的方法主要是通过萃取、柱层析等方法获得。随着theacrine新的药理活性的不断发现,已有的生产方法已经无法满足其要求。因此,解决来源短缺问题对theacrine的深入、广泛的研究和应用是非常重要的。Theacrine comes from bitter tea in southern China, where (Theobromagrandiflorum) and Camellia kucha (Camellia assamica var.kucha) are relatively high, and the existing methods are mainly obtained by extraction, column chromatography and other methods. With the continuous discovery of new pharmacological activities of theacrine, the existing production methods have been unable to meet its requirements. Therefore, it is very important for the in-depth and extensive research and application of theacrine to solve the problem of source shortage.

发明内容Contents of the invention

本发明所要解决的技术问题在于针对上述现有技术的不足,提供一种四甲基尿酸的合成方法。该方法以尿酸为原料,经嘌呤环上氮的完全甲基化反应在高压、高温条件下得到产物四甲基尿酸(theacrine),具有高转化率、高产率、高选择性和反应时间短等优势,适用于规模化合成。The technical problem to be solved by the present invention is to provide a synthetic method for tetramethyluric acid aiming at the above-mentioned deficiencies in the prior art. The method uses uric acid as a raw material to obtain the product tetramethyluric acid (theacrine) under high pressure and high temperature conditions through the complete methylation reaction of nitrogen on the purine ring, which has high conversion rate, high yield, high selectivity and short reaction time. Advantages, suitable for large-scale synthesis.

为解决上述技术问题,本发明采用的技术方案是:一种四甲基尿酸的合成方法,其特征在于,该方法包括以下步骤:For solving the problems of the technologies described above, the technical scheme adopted in the present invention is: a kind of synthetic method of tetramethyluric acid, it is characterized in that, this method comprises the following steps:

步骤一、按照1:(1.5~40)的摩尔比将尿酸和甲基化试剂置于高压反应釜内,将高压反应釜用保护气体置换三次后充保护气体至高压反应釜内压力为0.5MPa~10MPa,然后将高压反应釜的温度升至84℃~220℃,在搅拌速率为180rpm~2000rpm的条件下保温反应2h~48h;Step 1. Put uric acid and methylating reagent in the autoclave according to the molar ratio of 1:(1.5~40), replace the autoclave with protective gas three times, and then fill the autoclave with protective gas until the pressure inside the autoclave is 0.5MPa ~10MPa, then raise the temperature of the autoclave to 84°C~220°C, and keep the reaction for 2h~48h under the condition of stirring rate of 180rpm~2000rpm;

步骤二、采用冷凝水对步骤一中保温反应后的高压反应釜降温,并打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入冰水中进行搅拌析晶,抽滤后得到粗品;Step 2. Use condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and open the outlet valve of the high-pressure reactor to release the pressure. Stir and crystallize in ice water, and obtain the crude product after suction filtration;

步骤三、对步骤二中所述粗品进行重结晶,干燥后得到质量纯度不小于95%的四甲基尿酸。Step 3: recrystallize the crude product described in step 2, and obtain tetramethyluric acid with a mass purity of not less than 95% after drying.

上述的一种四甲基尿酸的合成方法,步骤一中尿酸和甲基化试剂的摩尔比为1:(5~20)。In the above-mentioned synthesis method of tetramethyluric acid, the molar ratio of uric acid and methylating reagent in step 1 is 1:(5-20).

上述的一种四甲基尿酸的合成方法,所述尿酸和甲基化试剂的摩尔比为1:10。The above-mentioned synthetic method of a kind of tetramethyluric acid, the molar ratio of described uric acid and methylation reagent is 1:10.

上述的一种四甲基尿酸的合成方法,步骤一中所述甲基化试剂为一卤代甲烷、硫酸二甲酯、N,N-二甲基甲酰胺、N,N-二甲基甲酰胺二甲缩醛、质量浓度为25%的四甲基氢氧化铵水溶液、甲醛和甲酸的混合溶液、碳酸二甲酯、原甲酸三甲酯、三甲基氯硅烷或三氟甲磺酸甲酯。The above-mentioned synthetic method of tetramethyluric acid, the methylating reagent described in step 1 is monohalomethane, dimethyl sulfate, N,N-dimethylformamide, N,N-dimethylformamide Amide dimethyl acetal, tetramethylammonium hydroxide aqueous solution with a mass concentration of 25%, a mixed solution of formaldehyde and formic acid, dimethyl carbonate, trimethyl orthoformate, trimethylchlorosilane or methyl trifluoromethanesulfonate ester.

上述的一种四甲基尿酸的合成方法,步骤一中所述保护气体为氮气或氩气。In the above-mentioned synthetic method of tetramethyluric acid, the protective gas described in step 1 is nitrogen or argon.

上述的一种四甲基尿酸的合成方法,步骤一中所述压力为2MPa~8MPa。In the above synthesis method of tetramethyluric acid, the pressure in step 1 is 2MPa-8MPa.

上述的一种四甲基尿酸的合成方法,步骤一中将高压反应釜的温度升至115℃~190℃,在搅拌速率为300rpm~1000rpm的条件下保温反应2.5h~18h。In the above-mentioned synthesis method of tetramethyluric acid, in step 1, the temperature of the autoclave is raised to 115° C. to 190° C., and the temperature is kept for 2.5 hours to 18 hours at a stirring rate of 300 rpm to 1000 rpm.

上述的一种四甲基尿酸的合成方法,步骤三中所述重结晶采用的溶剂为乙酸乙酯、二氯甲烷和乙腈中的一种与醇类按照(1~7):1的体积比混合的混合溶剂,或者为二氯甲烷、正己烷和醇类中的一种与丙酮按照1:(0.25~3)的体积比混合的混合溶剂,其中醇类为甲醇或乙醇。The above-mentioned synthetic method of a kind of tetramethyluric acid, the solvent that the recrystallization described in step 3 adopts is a kind of in ethyl acetate, methylene chloride and acetonitrile and alcohols according to the volume ratio of (1~7):1 A mixed mixed solvent, or a mixed solvent mixed with acetone in a volume ratio of 1:(0.25-3) among dichloromethane, n-hexane and alcohols, wherein the alcohols are methanol or ethanol.

本发明与现有技术相比具有以下优点:Compared with the prior art, the present invention has the following advantages:

1、本发明以尿酸为原料,经嘌呤环上氮的完全甲基化反应在高压、高温条件下得到产物四甲基尿酸(theacrine),具有高转化率、高产率、高选择性和反应时间短等优势,适用于规模化合成。1. The present invention uses uric acid as a raw material to obtain the product tetramethyluric acid (theacrine) under high pressure and high temperature conditions through the complete methylation reaction of nitrogen on the purine ring, which has high conversion rate, high yield, high selectivity and reaction time Short and other advantages, suitable for large-scale synthesis.

2、本发明采用无溶剂反应,甲基化试剂既是反应物,又是反应介质,在高压反应中可以最大限度的提高蒸汽分压,有利于提高反应产率。2. The present invention adopts solvent-free reaction, and the methylating reagent is not only a reactant, but also a reaction medium, which can maximize the steam partial pressure in the high-pressure reaction, which is beneficial to increase the reaction yield.

3、本发明采用高温、高压反应,缩短了反应时间、在一定程度上提高了效率和收率。同时兼顾了反应速率、产率及选择性。3. The present invention adopts high temperature and high pressure reaction, which shortens the reaction time and improves the efficiency and yield to a certain extent. At the same time, the reaction rate, yield and selectivity were taken into consideration.

4、本发明采用重结晶,提高了对杂质的分离能力,在一定程度上提高了总产率。4. The present invention adopts recrystallization, which improves the ability to separate impurities and improves the total yield to a certain extent.

下面结合实施例对本发明的技术方案做进一步的详细说明。The technical solutions of the present invention will be further described in detail below in conjunction with the embodiments.

具体实施方式Detailed ways

实施例1Example 1

步骤一、向500mL高压反应釜内加入1.6mol碘甲烷和0.08mol尿酸,密闭后向高压反应釜内充氮气至0.5MPa后放空,连续置换三次后向高压反应釜内充氮气至高压反应釜内压力为5MPa,打开冷凝水,调节搅拌速率为180rpm,将高压反应釜的温度升至84℃,保温反应2h;Step 1. Add 1.6mol methyl iodide and 0.08mol uric acid into the 500mL autoclave, seal it, fill the autoclave with nitrogen to 0.5MPa, then vent it, replace it three times continuously, and then fill the autoclave with nitrogen into the autoclave The pressure is 5MPa, turn on the condensed water, adjust the stirring rate to 180rpm, raise the temperature of the autoclave to 84°C, and keep it warm for 2h;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入300mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 300mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用乙酸乙酯和甲醇对步骤二中所述粗品进行重结晶,乙酸乙酯与甲醇的体积比为5:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)12.4g,产率69.2%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using ethyl acetate and methanol to recrystallize the crude product described in step 2, the volume ratio of ethyl acetate and methanol is 5:1, after drying at 105°C for 0.5 hour, tetramethyluric acid (1,3,7 , 9-tetramethyluric acid) 12.4g, yield 69.2%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例2Example 2

步骤一、向500mL高压反应釜内加入1.6mol硫酸二甲酯和0.16mol尿酸,密闭后向高压反应釜内充氩气至0.5MPa后放空,连续置换三次后向高压反应釜内充氩气至高压反应釜内压力为4MPa,打开冷凝水,调节搅拌速率为280rpm,将高压反应釜的温度升至180℃,保温反应2.5h;Step 1. Add 1.6mol dimethyl sulfate and 0.16mol uric acid into a 500mL autoclave, seal it, fill the autoclave with argon to 0.5MPa, and then vent it. After three consecutive replacements, fill the autoclave with argon to The pressure in the autoclave is 4MPa, turn on the condensed water, adjust the stirring rate to 280rpm, raise the temperature of the autoclave to 180°C, and keep it warm for 2.5h;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入400mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 400mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用二氯甲烷和甲醇对步骤二中所述粗品进行重结晶,二氯甲烷与甲醇的体积比为7:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)25.6g,产率71.4%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using dichloromethane and methanol to recrystallize the crude product described in step 2, the volume ratio of dichloromethane to methanol is 7:1, and after drying at 105°C for 0.5 hour, tetramethyluric acid (1,3,7 , 9-tetramethyluric acid) 25.6g, yield 71.4%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例3Example 3

步骤一、向500mL高压反应釜内加入1.6mol N,N-二甲基甲酰胺二甲缩醛和0.16mol尿酸,密闭后向高压反应釜内充氮气至0.5MPa后放空,连续置换三次后向高压反应釜内充氮气至高压反应釜内压力为2MPa,打开冷凝水,调节搅拌速率为300rpm,将高压反应釜的温度升至190℃,保温反应2.5h;Step 1. Add 1.6mol N,N-dimethylformamide dimethyl acetal and 0.16mol uric acid into a 500mL autoclave, seal it, fill the autoclave with nitrogen to 0.5MPa and then vent it, and replace it three times in a row. Fill the autoclave with nitrogen until the pressure in the autoclave is 2MPa, turn on the condensed water, adjust the stirring rate to 300rpm, raise the temperature of the autoclave to 190°C, and keep it warm for 2.5 hours;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入500mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 500mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用二氯甲烷和丙酮对步骤二中所述粗品进行重结晶,二氯甲烷与丙酮的体积比为4:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)28.4g,产率79.2%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using dichloromethane and acetone to recrystallize the crude product described in step 2, the volume ratio of dichloromethane to acetone is 4:1, after drying at 105°C for 0.5 hour, tetramethyluric acid (1,3,7 , 9-tetramethyluric acid) 28.4g, yield 79.2%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例4Example 4

步骤一、向500mL高压反应釜内加入0.8mol碳酸二甲酯和0.16mol尿酸,密闭后向高压反应釜内充氮气至0.5MPa后放空,连续置换三次后向高压反应釜内充氮气至高压反应釜内压力为8MPa,打开冷凝水,调节搅拌速率为400rpm,将高压反应釜的温度升至185℃,保温反应5h;Step 1. Add 0.8mol dimethyl carbonate and 0.16mol uric acid into a 500mL autoclave, seal it, fill the autoclave with nitrogen to 0.5MPa and then vent it, replace it three times in a row, then fill the autoclave with nitrogen to react under high pressure The pressure in the autoclave is 8MPa, turn on the condensed water, adjust the stirring rate to 400rpm, raise the temperature of the autoclave to 185°C, and keep the temperature for 5h;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入250mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 250mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用丙酮和甲醇对步骤二中所述粗品进行重结晶,丙酮与甲醇的体积比为3:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)30.8g,产率85.9%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using acetone and methanol to recrystallize the crude product described in step 2, the volume ratio of acetone and methanol is 3:1, and after drying at 105°C for 0.5 hour, tetramethyluric acid (1,3,7,9-tetramethyluric acid (1,3,7,9-tetramethyluric acid) is obtained. Methyluric acid) 30.8g, yield 85.9%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例5Example 5

步骤一、向500mL高压反应釜内加入4mol三甲基氯硅烷和0.16mol尿酸,密闭后向高压反应釜内充氮气至0.5MPa后放空,连续置换三次后向高压反应釜内充氮气至高压反应釜内压力为6MPa,打开冷凝水,调节搅拌速率为500rpm,将高压反应釜的温度升至115℃,保温反应18h;Step 1. Add 4mol trimethylchlorosilane and 0.16mol uric acid into a 500mL autoclave, seal it, fill the autoclave with nitrogen to 0.5MPa, then vent it, replace it three times in a row, and then fill the autoclave with nitrogen to react under high pressure The pressure in the autoclave is 6MPa, turn on the condensed water, adjust the stirring rate to 500rpm, raise the temperature of the autoclave to 115°C, and keep it warm for 18h;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入1000mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 1000mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用乙腈和乙醇对步骤二中所述粗品进行重结晶,乙腈与乙醇的体积比为1:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)29.4g,产率82.0%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using acetonitrile and ethanol to recrystallize the crude product described in step 2, the volume ratio of acetonitrile and ethanol is 1:1, and after drying at 105°C for 0.5 hours, tetramethyluric acid (1,3,7,9-tetramethyluric acid (1,3,7,9-tetramethyluric acid) is obtained. Methyluric acid) 29.4g, yield 82.0%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例6Example 6

步骤一、向500mL高压反应釜内加入3.2mol三氟甲磺酸甲酯和0.16mol尿酸,密闭后向高压反应釜内充氩气至0.5MPa后放空,连续置换三次后向高压反应釜内充氩气至高压反应釜内压力为3MPa,打开冷凝水,调节搅拌速率为1000rpm,将高压反应釜的温度升至190℃,保温反应8h;Step 1. Add 3.2mol methyl trifluoromethanesulfonate and 0.16mol uric acid into a 500mL autoclave, seal it, fill the autoclave with argon to 0.5MPa, and then empty it. After three consecutive replacements, fill the autoclave with Argon until the pressure in the autoclave is 3MPa, turn on the condensed water, adjust the stirring rate to 1000rpm, raise the temperature of the autoclave to 190°C, and keep it warm for 8h;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入600mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 600mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用正己烷和丙酮对步骤二中所述粗品进行重结晶,正己烷与丙酮的体积比为1:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)29.2g,产率81.5%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using n-hexane and acetone to recrystallize the crude product described in step 2, the volume ratio of n-hexane and acetone is 1:1, after drying at 105°C for 0.5 hour, tetramethyluric acid (1,3,7,9 -Tetramethyluric acid) 29.2g, yield 81.5%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例7Example 7

步骤一、向500mL高压反应釜内加入3.2mol N,N-二甲基甲酰胺和0.08mol尿酸,密闭后向高压反应釜内充氮气至0.5MPa后放空,连续置换三次后向高压反应釜内充氮气至高压反应釜内压力为10MPa,打开冷凝水,调节搅拌速率为1400rpm,将高压反应釜的温度升至200℃,保温反应2h;Step 1. Add 3.2mol N,N-dimethylformamide and 0.08mol uric acid into the 500mL autoclave, seal it, fill the autoclave with nitrogen to 0.5MPa and then vent it, replace it three times in a row, and put it into the autoclave Fill the autoclave with nitrogen until the pressure in the autoclave is 10MPa, turn on the condensed water, adjust the stirring rate to 1400rpm, raise the temperature of the autoclave to 200°C, and keep it warm for 2 hours;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入500mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 500mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用丙酮和甲醇对步骤二中所述粗品进行重结晶,丙酮与甲醇的体积比为3:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)15.23g,产率85.0%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using acetone and methanol to recrystallize the crude product described in step 2, the volume ratio of acetone and methanol is 3:1, and after drying at 105°C for 0.5 hour, tetramethyluric acid (1,3,7,9-tetramethyluric acid (1,3,7,9-tetramethyluric acid) is obtained. Methyluric acid) 15.23g, yield 85.0%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例8Example 8

步骤一、向500mL高压反应釜内加入0.15mol原甲酸三甲酯和0.1mol尿酸,密闭后向高压反应釜内充氩气至0.5MPa后放空,连续置换三次后向高压反应釜内充氩气至高压反应釜内压力为0.5MPa,打开冷凝水,调节搅拌速率为1800rpm,将高压反应釜的温度升至220℃,保温反应48h;Step 1. Add 0.15mol trimethyl orthoformate and 0.1mol uric acid into a 500mL autoclave, seal it, fill the autoclave with argon to 0.5MPa, then vent it, replace it three times in a row, and then fill the autoclave with argon When the pressure in the autoclave is 0.5MPa, turn on the condensed water, adjust the stirring rate to 1800rpm, raise the temperature of the autoclave to 220°C, and keep it warm for 48 hours;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入500mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 500mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用乙腈和乙醇对步骤二中所述粗品进行重结晶,乙腈与乙醇的体积比为1:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)17.92g,产率80%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using acetonitrile and ethanol to recrystallize the crude product described in step 2, the volume ratio of acetonitrile and ethanol is 1:1, and after drying at 105°C for 0.5 hours, tetramethyluric acid (1,3,7,9-tetramethyluric acid (1,3,7,9-tetramethyluric acid) is obtained. Methyluric acid) 17.92g, yield 80%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例9Example 9

步骤一、向500mL高压反应釜内加入甲醛和甲酸的混合溶液(含甲醛0.64mol,甲酸3.2mol)和0.16mol尿酸,密闭后向高压反应釜内充氮气至0.5MPa后放空,连续置换三次后向高压反应釜内充氮气至高压反应釜内压力为10MPa,打开冷凝水,调节搅拌速率为1000rpm,将高压反应釜的温度升至100℃,保温反应24h;Step 1. Add a mixed solution of formaldehyde and formic acid (containing 0.64 mol of formaldehyde and 3.2 mol of formic acid) and 0.16 mol of uric acid into a 500mL autoclave. After sealing, fill the autoclave with nitrogen to 0.5MPa and then empty it. After three consecutive replacements Fill the autoclave with nitrogen until the pressure in the autoclave is 10MPa, turn on the condensed water, adjust the stirring rate to 1000rpm, raise the temperature of the autoclave to 100°C, and keep it warm for 24 hours;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入500mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 500mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用二氯甲烷和乙醇对步骤二中所述粗品进行重结晶,二氯甲烷与乙醇的体积比为4:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)29.5g,产率82.3%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using dichloromethane and ethanol to recrystallize the crude product described in step 2, the volume ratio of dichloromethane to ethanol is 4:1, after drying at 105°C for 0.5 hour, tetramethyluric acid (1,3,7 , 9-tetramethyluric acid) 29.5g, yield 82.3%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

实施例10Example 10

步骤一、向500mL高压反应釜内加入质量浓度为25%的四甲基氢氧化铵水溶液(含四甲基氢氧化铵1mol)和0.08mol尿酸,密闭后向高压反应釜内充氩气至0.5MPa后放空,连续置换三次后向高压反应釜内充氩气至高压反应釜内压力为10MPa,打开冷凝水,调节搅拌速率为2000rpm,将高压反应釜的温度升至200℃,保温反应2h;Step 1. Add a 25% aqueous solution of tetramethylammonium hydroxide (containing 1 mol of tetramethylammonium hydroxide) and 0.08 mol of uric acid into a 500 mL autoclave, and fill the autoclave with argon to 0.5 After the MPa is vented, after three consecutive replacements, fill the autoclave with argon until the pressure in the autoclave is 10MPa, turn on the condensed water, adjust the stirring rate to 2000rpm, raise the temperature of the autoclave to 200°C, and keep it warm for 2 hours;

步骤二、增大冷凝水流量对步骤一中保温反应后的高压反应釜降温,并缓慢打开高压反应釜的出气阀泄压,待高压反应釜压力降至0MPa时开釜出料,将反应后的物料倒入500mL冰水中进行搅拌析晶,抽滤后得到粗品;Step 2: Increase the flow rate of condensed water to cool down the high-pressure reactor after the heat preservation reaction in step 1, and slowly open the outlet valve of the high-pressure reactor to release the pressure. The material was poured into 500mL ice water and stirred and crystallized, and the crude product was obtained after suction filtration;

步骤三、采用丙酮和乙醇对步骤二中所述粗品进行重结晶,丙酮与乙醇的体积比为2:1,105℃干燥0.5小时后得到四甲基尿酸(1,3,7,9-四甲基尿酸)13.44g,产率75%,经HPLC检测四甲基尿酸的质量纯度不小于95%。Step 3, using acetone and ethanol to recrystallize the crude product described in step 2, the volume ratio of acetone and ethanol is 2:1, and after drying at 105°C for 0.5 hours, tetramethyluric acid (1,3,7,9-tetramethyluric acid (1,3,7,9-tetramethyluric acid) is obtained. Methyluric acid) 13.44g, yield 75%, the mass purity of tetramethyluric acid detected by HPLC is not less than 95%.

经检测,本实施例制备的产物四甲基尿酸的熔点为222℃~225℃;MS:225(M+H);1HNMR(CDCl3):3.23(s3H),3.41(s3H),3.52(s3H),3.61(s3H)。After testing, the melting point of the product tetramethyluric acid prepared in this example is 222°C-225°C; MS: 225 (M+H); 1 HNMR (CDCl 3 ): 3.23 (s3H), 3.41 (s3H), 3.52 ( s3H), 3.61 (s3H).

以上所述,仅是本发明的较佳实施例,并非对本发明做任何限制,凡是根据发明技术实质对以上实施例所作的任何简单修改、变更以及等效结构变化,均仍属于本发明技术方案的保护范围内。The above are only preferred embodiments of the present invention, and do not limit the present invention in any way. All simple modifications, changes and equivalent structural changes made to the above embodiments according to the technical essence of the invention still belong to the technical solution of the present invention. within the scope of protection.

Claims (8)

1. a synthetic method for tetramethyl-uric acid, is characterized in that, the method comprises the following steps:
Step 1, according to 1:(1.5~40) mol ratio uric acid and methylating reagent are placed in autoclave, after autoclave is replaced to three times with shielding gas, filling shielding gas to high pressure reacting kettle inner pressure is 0.5MPa~10MPa, then the temperature of autoclave is risen to 84 ℃~220 ℃, insulation reaction 2h~48h under the condition that is 180rpm~2000rpm in stir speed (S.S.);
Step 2, the autoclave cooling after adopting water of condensation to insulation reaction in step 1, and the air outlet valve pressure release of opening autoclave, until autoclave Pressure Drop, open still discharging during to 0MPa, reacted material is poured in frozen water and carried out stirring and crystallizing, after suction filtration, obtain crude product;
Step 3, crude product described in step 2 is carried out to recrystallization, obtain quality purity after dry to be not less than 95% tetramethyl-uric acid.
2. the synthetic method of a kind of tetramethyl-uric acid according to claim 1, is characterized in that, in step 1, the mol ratio of uric acid and methylating reagent is 1:(5~20).
3. the synthetic method of a kind of tetramethyl-uric acid according to claim 2, is characterized in that, the mol ratio of described uric acid and methylating reagent is 1:10.
4. according to the synthetic method of a kind of tetramethyl-uric acid described in claim 1,2 or 3, it is characterized in that, methylating reagent described in step 1 is a methyl halide, methyl-sulfate, N, the mixing solutions of tetramethylammonium hydroxide aqueous solution, formaldehyde and formic acid that dinethylformamide, DMF dimethylacetal, mass concentration are 25%, methylcarbonate, trimethyl orthoformate, trimethylchlorosilane or trifluoromethanesulfonic acid methyl esters.
5. according to the synthetic method of a kind of tetramethyl-uric acid described in claim 1,2 or 3, it is characterized in that, shielding gas described in step 1 is nitrogen or argon gas.
6. the synthetic method of a kind of tetramethyl-uric acid according to claim 1, is characterized in that, pressure described in step 1 is 2MPa~8MPa.
7. the synthetic method of a kind of tetramethyl-uric acid according to claim 1, is characterized in that, the temperature of autoclave is risen to 115 ℃~190 ℃, insulation reaction 2.5h~18h under the condition that is 300rpm~1000rpm in stir speed (S.S.) in step 1.
8. the synthetic method of a kind of tetramethyl-uric acid according to claim 1, it is characterized in that, the solvent that recrystallization described in step 3 adopts is a kind of and alcohols in ethyl acetate, methylene dichloride and acetonitrile according to (1~7): the mixed solvent that 1 volume ratio is mixed, or be that a kind of and acetone in methylene dichloride, normal hexane and alcohols is according to 1:(0.25~3) the mixed solvent that mixes of volume ratio, wherein alcohols is methyl alcohol or ethanol.
CN201410344230.XA 2014-07-18 2014-07-18 A kind of synthetic method of tetramethyluric acid Expired - Fee Related CN104086550B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410344230.XA CN104086550B (en) 2014-07-18 2014-07-18 A kind of synthetic method of tetramethyluric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410344230.XA CN104086550B (en) 2014-07-18 2014-07-18 A kind of synthetic method of tetramethyluric acid

Publications (2)

Publication Number Publication Date
CN104086550A true CN104086550A (en) 2014-10-08
CN104086550B CN104086550B (en) 2016-08-17

Family

ID=51634338

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410344230.XA Expired - Fee Related CN104086550B (en) 2014-07-18 2014-07-18 A kind of synthetic method of tetramethyluric acid

Country Status (1)

Country Link
CN (1) CN104086550B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106046004A (en) * 2016-06-06 2016-10-26 上海佰特因医药科技有限公司 Total synthesis method for theacrine
CN107326053A (en) * 2017-06-19 2017-11-07 湖州恒睿营养健康科技有限公司 Two step enzyme methods prepare 1,3,7,9 tetramethyluric acids
CN108912121A (en) * 2018-08-08 2018-11-30 南京纽邦生物科技有限公司 Preparation method, the preparation method of intermediate and intermediate of three kinds of methyl-uric acid class compounds
CN115536598A (en) * 2022-09-15 2022-12-30 青岛科技大学 Novel synthesis method of 1,4-dimethyl-2,5-piperazinedione compound

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111620872B (en) * 2020-05-19 2021-02-09 南京纽邦生物科技有限公司 Synthetic method of tetramethyluric acid and special catalyst thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767182A (en) * 1953-08-08 1956-10-16 Boehringer Sohn Ingelheim Process of n-alkylating compounds having reactive imino groups
CN101289448A (en) * 2008-06-18 2008-10-22 中山大学 The preparation method of 1,3,7,9-tetramethyluric acid
WO2013093099A1 (en) * 2011-12-22 2013-06-27 Piramal Imaging Sa Stabilization of peptidic radiopharmaceuticals using uric acid or derivatives thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767182A (en) * 1953-08-08 1956-10-16 Boehringer Sohn Ingelheim Process of n-alkylating compounds having reactive imino groups
CN101289448A (en) * 2008-06-18 2008-10-22 中山大学 The preparation method of 1,3,7,9-tetramethyluric acid
WO2013093099A1 (en) * 2011-12-22 2013-06-27 Piramal Imaging Sa Stabilization of peptidic radiopharmaceuticals using uric acid or derivatives thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BRANKO STANOVNIK ET AL: "《MeBranko Stanovnik et althylation of some oxopurines and 1,2,4-triazoles with N,N-dimethylformamide dimethyl acetal》", 《VESTNIK SLOVENSKEGA KEMIJSKEGA DRUSTVA》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106046004A (en) * 2016-06-06 2016-10-26 上海佰特因医药科技有限公司 Total synthesis method for theacrine
CN106046004B (en) * 2016-06-06 2018-05-15 上海佰特因医药科技有限公司 A kind of total synthesis method of 1,3,7,9- tetramethyluric acids
CN107326053A (en) * 2017-06-19 2017-11-07 湖州恒睿营养健康科技有限公司 Two step enzyme methods prepare 1,3,7,9 tetramethyluric acids
CN107326053B (en) * 2017-06-19 2019-10-08 浙江华睿生物技术有限公司 Two step enzyme methods prepare 1,3,7,9- tetramethyluric acid
CN108912121A (en) * 2018-08-08 2018-11-30 南京纽邦生物科技有限公司 Preparation method, the preparation method of intermediate and intermediate of three kinds of methyl-uric acid class compounds
CN115536598A (en) * 2022-09-15 2022-12-30 青岛科技大学 Novel synthesis method of 1,4-dimethyl-2,5-piperazinedione compound
CN115536598B (en) * 2022-09-15 2024-04-02 青岛科技大学 New synthesis method of 1, 4-dimethyl-2, 5-piperazine dione compound

Also Published As

Publication number Publication date
CN104086550B (en) 2016-08-17

Similar Documents

Publication Publication Date Title
CN104086550B (en) A kind of synthetic method of tetramethyluric acid
CN102766139B (en) Azilsartan polymorphic substance and preparation method thereof
WO2016165496A1 (en) Method for preparing deoxycholic acid
WO2022151615A1 (en) Synthesis method for tianagliflozin intermediate
CN104356012B (en) The preparation method of sarpogrelate hydrochloride light degradation impurity
CN108623456A (en) The preparation method of butylphenyl phthaleine and its pharmaceutical intermediate
CN111620844B (en) The preparation method of α-acetyl-γ-butyrolactone
CN105399735A (en) Empagliflozin intermediate, and preparation method and application thereof
ES2386678T3 (en) Preparation procedure for 4 '- [[4-methyl-6- (1-methyl-1H-benzimidazol-2-yl) -2-propyl-1H-benzimidazol-1yl] methyl] biphenyl-2-carboxylic acid (telmisartan)
WO2017063327A1 (en) Novel c-spiro-o-glycoside compound intermediate and preparation method therefor
CN103180325A (en) Method for preparing beta-artemether
CN109748902A (en) A kind of hydrochloric acid peace sieve replaces the preparation method of Buddhist nun
EP4406949A1 (en) Method for preparing lifitegrast and intermediate compound of lifitegrast
WO2021218275A1 (en) Method for synthesizing and refining 4-fluorobenzoylacetonitrile
CN115974758A (en) Carboxymethyl ketone compound and preparation method thereof
CN116120236A (en) Preparation method of 6-chloro-2-methyl-2H-indazole-5-amine
WO2015085827A1 (en) Method for preparing silodosin and intermediate thereof
CN105061327B (en) A kind of synthetic method of sulfamethoxyplridazine
CN102702278B (en) Method for synthesizing clindamycin 3,4-isopropylidene
CN108586450B (en) Recrystallization purification method of choline M receptor anticaking agent
CN114989091A (en) Preparation method of glutamyl ethyl imidazole
CN108976407B (en) A kind of preparation method of water-soluble natural vitamin E
CN103044356A (en) New method for synthesizing levocetirizine and key intermediate thereof
JP6124562B2 (en) 4 '-[[2-n-propyl-4-methyl-6- (1-methylbenzimidazol-2-yl) -benzimidazol-1-yl] -methyl] -biphenyl-2-carboxylic acid ammonium salt crystal
CN109988070B (en) Intermediate of trans-1-hydroxy-1-(trifluoromethyl)-3-aminocyclobutane hydrochloride and preparation method and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160817

Termination date: 20170718

CF01 Termination of patent right due to non-payment of annual fee